Equity Overview
Price & Market Data
Price: $1.38
Daily Change: +$0.0096 / 0.70%
Range: $1.35 - $1.42
Market Cap: $26,594,550
Volume: 13,538
Performance Metrics
1 Week: 2.59%
1 Month: -13.44%
3 Months: -87.75%
6 Months: -87.22%
1 Year: -86.67%
YTD: -87.99%
Company Details
Employees: 2
Sector: Health technology
Industry: Biotechnology
Country:
Details
OSR Holdings, Inc. develops a portfolio of therapies and healthcare solutions in the United States, Europe, and South Korea. The company develops immunotherapy products, including VXM01, VXM04, VXM06, VXM08, and VXM10 for cancer treatment; DRT102-sp for the treatment of lumbar stenosis, disc herniaton, and spinal; DRT102-dt for dental augmentation; DRT102-nu for nonunion bone fracture; and DRT101 for osteoarthritis. It also provides medical devices. The company is based in Bellevue, Washington.